Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.
about
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomicMulti-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancerAmplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerMarkers of resistance to anti-EGFR therapy in colorectal cancerDeregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimusEmergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabKirsten Ras* oncogene: Significance of its discovery in human cancer researchBiomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASPharmacologic resistance in colorectal cancer: a reviewThe Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyPersonalized treatment for advanced colorectal cancer: KRAS and beyondEGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysisPIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysisUnique features of the human brainstem and cerebellumPrimary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategiesAcquired resistance to EGFR-targeted therapies in colorectal cancerMolecular pathology of lung cancer: key to personalized medicine.Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis.A perspective on anti-EGFR therapies targeting triple-negative breast cancerMechanisms of resistance to anti-EGFR therapy in colorectal cancerConcordant analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression between primary colorectal cancer and matched metastasesPaxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionA let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapyDNA copy number gains in malignant pleural mesotheliomaExpression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer CellsPhase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancerSelective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.Where now for anti-EGF receptor therapies in colorectal cancer?The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.Frequent activation of EGFR in advanced chordomas.Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancersEpidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer.ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.
P2860
Q21128654-990FD74A-9719-4793-9861-820E9BD28FB6Q21142734-5000BDD3-A199-4F23-A24F-9E1DCB5A7AC0Q24563539-E72AED9F-0A27-437E-873C-E00BF0BC778FQ24598640-724268AC-B9F2-46CD-8B4D-3B9593247236Q24600932-E124C018-7410-4B37-866A-170740F5DB87Q24604601-9DC3B22E-2E88-4780-8A65-B4B439B7B71DQ24652337-692A83BB-26A9-41F6-A2BF-3CFD4EAFB701Q26751212-646E215A-8E95-4386-8287-8CE558D6AFE4Q26766535-CE88A590-E66C-4D4C-8262-2D4968621B69Q26769850-35F1DEC1-F23A-4F9F-A14D-07BF8DEB74B5Q26777125-935ADF2E-2FCD-46BF-A431-5EC62F0BE85EQ26822817-C6DE68CF-6179-48E3-83FA-0F8DA9449263Q26865056-088DA864-3B7D-44EC-9EF2-E77A397336B1Q26992267-854356BF-4379-4F93-BDAD-7D62CB2CE0FBQ27012920-AD165266-8982-4FA3-A4C9-0E7A7D1E63C9Q27015224-AE7746C0-83BF-49EB-A68B-1B3B06235BBFQ27022741-F7A2E285-C33E-4399-8277-289EF4E8B5D2Q27691299-557C1A37-84D2-42EC-B7FA-2BF89F7F4B5BQ27691330-855AD0A7-5748-49A5-BBF5-6B42213063A7Q27852057-59DF109B-E686-474D-BA95-64EBF75E5C88Q27852105-AF25FFD6-0017-4BF8-B667-F3540010AC60Q27852970-DFA21F10-A735-4C01-BD6A-5C423F710511Q28069867-EC5F5A7C-7A21-4FF0-A4E9-2B1A174FD4F4Q28074073-C4B856B2-005B-4AE3-9FD0-1F131109EBE2Q28088489-62F207BC-C045-4DB5-8229-982D6FEE9643Q28263339-CBC3DFEA-CE61-46C9-A5AE-A627E1A473EDQ28287088-38ED433A-0687-4D00-AE0C-9CB5F0E9EC6EQ28395184-D65C9148-6452-49BD-98E3-5D17EF3A24E1Q28534094-3A9A38DB-FCEA-4B8E-BB94-D874CB1D2346Q28534997-6D78C0AE-7470-4173-A4C1-CFDACAFF0262Q30978860-D2C8643A-99FB-4D61-8236-E24A3187311CQ31038305-707F73B9-E780-4C4A-991D-0C17802A22B9Q33274011-A7D08A9E-AAA2-458C-B727-B382B1EC26B2Q33274473-CFBFB07F-36B4-4C1B-B1EB-921421D824A4Q33313648-095829BF-6F66-4636-B1E5-F868F1276C30Q33359798-42F05BBF-BC76-4132-A5BE-56390AC25837Q33379276-1528808A-8EEC-4CAA-94B0-6056A0C44A2EQ33497634-BC76AE6D-47DC-47D5-99B9-948DAC7A8A97Q33556004-48F81538-3058-4378-BED6-0094B06F08F6Q33601653-E5ACCE57-3825-4091-BC05-C58A58356243
P2860
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Gene copy number for epidermal ...... rectal cancer: a cohort study.
@en
Gene copy number for epidermal growth factor receptor
@nl
type
label
Gene copy number for epidermal ...... rectal cancer: a cohort study.
@en
Gene copy number for epidermal growth factor receptor
@nl
prefLabel
Gene copy number for epidermal ...... rectal cancer: a cohort study.
@en
Gene copy number for epidermal growth factor receptor
@nl
P2093
P50
P1433
P1476
Gene copy number for epidermal ...... rectal cancer: a cohort study.
@en
P2093
Giovanna Marrapese
Marcello Gambacorta
Mauro Moroni
Silvia Benvenuti
P304
P356
10.1016/S1470-2045(05)70102-9
P50
P577
2005-05-01T00:00:00Z